Bringing AI algorithms to Medicine: SimplicityBio acquired by Precision for Medicine
06.03.2019
Venture Kick alumni SimplicityBio, provides unlike other AI solutions, the possibility to use multiple biomarkers simultaneously in a white-box design, announces being acquired by Precision for Medicine developing QuartzBio™, a multiomic data integration and informatics platform. Read co-founder and CEO Matthew Hall's vision for AI algorithms in Medicine.
 |
 |
 Matthew Hall and Pedro Faustino, founders of SimplicityBio
|
|
In a few words, can you summarize the core innovation and mission of SimplicityBio?
SimplicityBio’s core mission is to extract knowledge and insight from clinical data to lead to disease mechanism understanding, drug target discovery, biomarker identification, patient stratification, and drug repositioning. To do so it uses a proprietary machine learning–driven technology to analyze biological, clinical, and digital data streams to interactively provide clients with intuitive and interpretable biomarker-based modes.
Which opportunity does this acquisition offer for SimplicityBio and Precision for Medicine?
This acquisition allows us to better serve our customers and in fine to targeting patient treatments more precisely and effectively. As artificial intelligence approaches are only as good as the data we can apply them to; joining Precision for Medicine and integrating our AI algorithms into QuartzBioTM multi-omic data integration and informatics platform is a giant leap forward for SimplicityBio and Precision’s clients. We can now provide them with the most robust, sophisticated end-to-end solution for the “big data” challenge observed in biomarker-guided drug development—furthering their mission of maximizing the value and utility of biomarker data generated in the course of a clinical trial.
How do you see your next steps for SimplicityBio?
The whole team will integrate Precision’s team to ensure the integration and growth of the technology and continuity of our mission extracting knowledge from clinical data to target patient treatments more precisely and effectively.
Back in 2015, you were granted with Venture Kick, how did it help you to get to where you are today?
The Venture Kick camps and jury presentations were pivotal moments in the inception of the company by shifting our mindset to a sale and customer-oriented one, we then developed our technology to solve real customer problematics. The financial support fueled our early growth by allowing us to go to conferences and meet our customers.
www.venturekick.ch/SimplicityBio